NUVIDENZA Trademark

Trademark Overview


On Thursday, November 17, 2022, a trademark application was filed for NUVIDENZA with the United States Patent and Trademark Office. The USPTO has given the NUVIDENZA trademark a serial number of 97681647. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, June 5, 2024. This trademark is owned by Novavax, Inc.. The NUVIDENZA trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines
nuvidenza

General Information


Serial Number97681647
Word MarkNUVIDENZA
Filing DateThursday, November 17, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, June 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 10, 2023

Trademark Statements


Goods and ServicesVaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovavax, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Party NameNovavax, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events


Event DateEvent Description
Monday, November 21, 2022NEW APPLICATION ENTERED
Thursday, December 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 30, 2023ASSIGNED TO EXAMINER
Tuesday, September 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 10, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 5, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 4, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 4, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 4, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 5, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, June 5, 2024SOU EXTENSION 1 FILED
Wednesday, June 5, 2024SOU EXTENSION 1 GRANTED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords


nuvidenza vaccines